Suchergebnisse - "Mortezaee, Keywan"

PubPharm (222)

1

Corrigendum to "Therapeutic effects of melatonin-treated bone marrow mesenchymal stem cells (BMSC) in a rat model of Alzheimer's disease" [J. Chem. Neuroanat. 108 (2020) 101804

enthalten in: Journal of chemical neuroanatomy | 2024

von Ramezani, M. | Komaki, A. | Hashemi-Firouzi, N. | +3

ErratumFor: J Chem Neuroanat. 2020 Oct;108:101804. - PMID 32470495

2

FOXP3 (in)stability and cancer immunotherapy

enthalten in: Cytokine | 2024

von Mortezaee, K.

3

Immunotherapy of Human Melanoma : Past, Present, Future

enthalten in: Current medicinal chemistry | 2024

von Mortezaee, K. | Majidpoor, J.

4

Selective targeting or reprogramming of intra-tumoral Tregs

enthalten in: Medical oncology (Northwood, London, England) | 2024

von Mortezaee, K.

5

Selective targeting or reprogramming of intra-tumoral Tregs

enthalten in: Medical oncology | 2024

von Mortezaee, K.

6

WNT/β-catenin regulatory roles on PD-(L)1 and immunotherapy responses

enthalten in: Clinical and experimental medicine | 2024

von Mortezaee, K.

7

WNT/β-catenin regulatory roles on PD-(L)1 and immunotherapy responses

enthalten in: Clinical and experimental medicine | 2024

von Mortezaee, K.

8

An Update of Extracellular Vesicle Involvement in different Steps of Cancer Metastasis and Targeting Strategies

enthalten in: Current medicinal chemistry | 2024

von Mortezaee, K. | Majidpoor, J.

9

Liquid biopsy in colorectal cancer

enthalten in: Clinica chimica acta; international journal of clinical chemistry | 2024

von Najafi, S. | Majidpoor, J. | Mortezaee, K.

10

Modifying CAR-T cells with anti-checkpoints in cancer immunotherapy : A focus on anti PD-1/PD-L1 antibodies

enthalten in: Life sciences | 2024

von Najafi, S. | Mortezaee, K.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]